<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39354320</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1940-6029</ISSN><JournalIssue CitedMedium="Internet"><Volume>2855</Volume><PubDate><Year>2025</Year></PubDate></JournalIssue><Title>Methods in molecular biology (Clifton, N.J.)</Title><ISOAbbreviation>Methods Mol Biol</ISOAbbreviation></Journal><ArticleTitle>CE-MS-Based Clinical Metabolomics of Human Plasma.</ArticleTitle><Pagination><StartPage>389</StartPage><EndPage>423</EndPage><MedlinePgn>389-423</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/978-1-0716-4116-3_23</ELocationID><Abstract><AbstractText>Capillary electrophoresis coupled to mass spectrometry (CE-MS) has emerged as a powerful analytical technique with significant implications for clinical research and diagnostics. The integration of information from CE and MS strengthens confidence in the identification of compounds present in clinical samples. The ability of CE to separate molecules based on their electrophoretic mobility coupled to MS enables the accurate identification and quantification of analytes, even in complex biological matrices such as human plasma.Here, we present a detailed protocol for an untargeted metabolomics study using CE-MS and its application in a study on human plasma from patients suffering Long COVID syndrome. The protocol ranges from sample preparation to biological interpretation, detailing a workflow enabling the analysis of cationic and anionic compounds, metabolite identification, and data processing.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Mamani-Huanca</LastName><ForeName>Maricruz</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centro de Metabol&#xf3;mica y Bioan&#xe1;lisis (CEMBIO), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Mart&#xed;nez</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centro de Metabol&#xf3;mica y Bioan&#xe1;lisis (CEMBIO), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez-L&#xf3;pez</LastName><ForeName>&#xc1;ngeles</ForeName><Initials>&#xc1;</Initials><AffiliationInfo><Affiliation>Centro de Metabol&#xf3;mica y Bioan&#xe1;lisis (CEMBIO), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez-Gonz&#xe1;lvez</LastName><ForeName>&#xc1;ngeles</ForeName><Initials>&#xc1;</Initials><AffiliationInfo><Affiliation>Centro de Metabol&#xf3;mica y Bioan&#xe1;lisis (CEMBIO), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alb&#xf3;niga</LastName><ForeName>Oihane E</ForeName><Initials>OE</Initials><AffiliationInfo><Affiliation>Centro de Metabol&#xf3;mica y Bioan&#xe1;lisis (CEMBIO), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gradillas</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centro de Metabol&#xf3;mica y Bioan&#xe1;lisis (CEMBIO), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbas</LastName><ForeName>Coral</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centro de Metabol&#xf3;mica y Bioan&#xe1;lisis (CEMBIO), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez-Ruiz</LastName><ForeName>V&#xed;ctor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Centro de Metabol&#xf3;mica y Bioan&#xe1;lisis (CEMBIO), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Madrid, Spain. victor.gonzalezruiz@ceu.es.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Methods Mol Biol</MedlineTA><NlmUniqueID>9214969</NlmUniqueID><ISSNLinking>1064-3745</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019075" MajorTopicYN="Y">Electrophoresis, Capillary</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055432" MajorTopicYN="Y">Metabolomics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013058" MajorTopicYN="Y">Mass Spectrometry</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010949" MajorTopicYN="N">Plasma</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CE-MS</Keyword><Keyword MajorTopicYN="N">Clinical metabolomics</Keyword><Keyword MajorTopicYN="N">Human plasma</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Polar metabolome</Keyword><Keyword MajorTopicYN="N">Untargeted metabolomics</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>7</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>7</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>23</Hour><Minute>38</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39354320</ArticleId><ArticleId IdType="doi">10.1007/978-1-0716-4116-3_23</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mamani-Huanca M, Villase&#xf1;or A, Gonzalez-Riano C et al (2023) Capillary electrophoresis mass spectrometry-based untargeted metabolomics to approach disease diagnosis. TRAC-Trend Anal Chem 162:117049</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trac.2023.117049</ArticleId></ArticleIdList></Reference><Reference><Citation>Mamani-Huanca M, la Fuente AG, de Otero A et al (2021) Enhancing confidence of metabolite annotation in Capillary Electrophoresis-Mass Spectrometry untargeted metabolomics with relative migration time and in-source fragmentation. J Chromatogr A 1635:461758</Citation><ArticleIdList><ArticleId IdType="pubmed">33302137</ArticleId><ArticleId IdType="doi">10.1016/j.chroma.2020.461758</ArticleId></ArticleIdList></Reference><Reference><Citation>Codesido S, Drouin N, Ferr&#xe9; S et al (2021) New insights into the conversion of electropherograms to the effective electrophoretic mobility scale. Electrophoresis 42:1875&#x2013;1884</Citation><ArticleIdList><ArticleId IdType="pubmed">34216494</ArticleId><ArticleId IdType="pmc">8518790</ArticleId><ArticleId IdType="doi">10.1002/elps.202000333</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-L&#xf3;pez &#xc1;, Ciborowski M, Niklinski J et al (2022) Optimization of capillary electrophoresis coupled to negative mode electrospray ionization-mass spectrometry using polyvinyl alcohol coated capillaries. Application to a study on non-small cell lung cancer. Anal Chim Acta 1226:340259</Citation><ArticleIdList><ArticleId IdType="pubmed">36068059</ArticleId><ArticleId IdType="doi">10.1016/j.aca.2022.340259</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobolkina E, Pamies D, Zurich M-G et al (2023) Bringing CE-MS into the regulatory toxicology toolbox: Application to neuroinflammation screening. Microchem J 193:109048</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.microc.2023.109048</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishibashi Y, Harada S, Takeuchi A et al (2021) Reliability of urinary charged metabolite concentrations in a large-scale cohort study using capillary electrophoresis-mass spectrometry. Sci Rep 11:7407</Citation><ArticleIdList><ArticleId IdType="pubmed">33795760</ArticleId><ArticleId IdType="pmc">8016858</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-86600-9</ArticleId></ArticleIdList></Reference><Reference><Citation>ISO (2021) Molecular in vitro diagnostic examinations &#x2014; specifications for pre-examination processes in metabolomics in urine, venous blood serum and plasma, https://www.iso.org/standard/74605.html</Citation></Reference><Reference><Citation>Ghini V, Abuja PM, Polasek O et al (2022) Impact of the pre-examination phase on multicenter metabolomic studies. New Biotechnol 68:37&#x2013;47</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbt.2022.01.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Khadka M, Todor A, Maner-Smith KM et al (2019) The effect of anticoagulants, temperature, and time on the human plasma metabolome and lipidome from healthy donors as determined by liquid chromatography-mass spectrometry. Biomolecules 9:200</Citation><ArticleIdList><ArticleId IdType="pubmed">31126114</ArticleId><ArticleId IdType="pmc">6571950</ArticleId><ArticleId IdType="doi">10.3390/biom9050200</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang Z, Chong J, Zhou G et al (2021) MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights. Nucleic Acids Res 49:W388&#x2013;W396</Citation><ArticleIdList><ArticleId IdType="pubmed">34019663</ArticleId><ArticleId IdType="pmc">8265181</ArticleId><ArticleId IdType="doi">10.1093/nar/gkab382</ArticleId></ArticleIdList></Reference><Reference><Citation>Gil-De-La-Fuente A, Godzien J, Saugar S et al (2019) CEU Mass Mediator 3.0: a metabolite annotation tool. J Proteome Res 18:797&#x2013;802</Citation><ArticleIdList><ArticleId IdType="pubmed">30574788</ArticleId><ArticleId IdType="doi">10.1021/acs.jproteome.8b00720</ArticleId></ArticleIdList></Reference><Reference><Citation>Drouin N, Pezzatti J, Gagnebin Y et al (2018) Effective mobility as a robust criterion for compound annotation and identification in metabolomics: toward a mobility-based library. Anal Chim Acta 1032:178&#x2013;187</Citation><ArticleIdList><ArticleId IdType="pubmed">30143215</ArticleId><ArticleId IdType="doi">10.1016/j.aca.2018.05.063</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Sena T, Luongo G, Sanjuan-Herr&#xe1;ez D et al (2019) Monitoring of system conditioning after blank injections in untargeted UPLC-MS metabolomic analysis. Sci Rep 9:1&#x2013;9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-46371-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Boccard J, Gonz&#xe1;lez-Ruiz V, Codesido S, et al (2020) Mass spectrometry metabolomic data handling for biomarker discovery. pp 369&#x2013;388</Citation></Reference><Reference><Citation>Gonz&#xe1;lez-Ruiz V, Gagnebin Y, Drouin N et al (2018) ROMANCE: a new software tool to improve data robustness and feature identification in CE-MS metabolomics. Electrophoresis 39:1222&#x2013;1232</Citation><ArticleIdList><ArticleId IdType="pubmed">29292828</ArticleId><ArticleId IdType="doi">10.1002/elps.201700427</ArticleId></ArticleIdList></Reference><Reference><Citation>Reijeng JC, Martens JHPA, Giuliani A et al (2002) Pherogram normalization in capillary electrophoresis and micellar electrokinetic chromatography analyses in cases of sample matrix-induced migration time shifts. J Chromatogr B Analyt Technol Biomed Life Sci 770:45&#x2013;51</Citation><ArticleIdList><ArticleId IdType="pubmed">12013243</ArticleId><ArticleId IdType="doi">10.1016/S0378-4347(01)00527-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiffman C, Petrick L, Perttula K et al (2019) Filtering procedures for untargeted lc-ms metabolomics data. BMC Bioinformatics 20:1&#x2013;10</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-019-2871-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Naz S, Vallejo M, Garc&#xed;a A et al (2014) Method validation strategies involved in non-targeted metabolomics. J Chromatogr A 1353:99&#x2013;105</Citation><ArticleIdList><ArticleId IdType="pubmed">24811151</ArticleId><ArticleId IdType="doi">10.1016/j.chroma.2014.04.071</ArticleId></ArticleIdList></Reference><Reference><Citation>Thonusin C, IglayReger HB, Soni T et al (2017) Evaluation of intensity drift correction strategies using MetaboDrift, a normalization tool for multi-batch metabolomics data. J Chromatogr A 1523:265&#x2013;274</Citation><ArticleIdList><ArticleId IdType="pubmed">28927937</ArticleId><ArticleId IdType="pmc">5788449</ArticleId><ArticleId IdType="doi">10.1016/j.chroma.2017.09.023</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumner LW, Amberg A, Barrett D et al (2007) Proposed minimum reporting standards for chemical analysis. Metabolomics 3:211&#x2013;221</Citation><ArticleIdList><ArticleId IdType="pubmed">24039616</ArticleId><ArticleId IdType="pmc">3772505</ArticleId><ArticleId IdType="doi">10.1007/s11306-007-0082-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Schymanski EL, Jeon J, Gulde R et al (2014) Identifying small molecules via high resolution mass spectrometry: communicating confidence. Environ Sci Technol 48:2097&#x2013;2098</Citation><ArticleIdList><ArticleId IdType="pubmed">24476540</ArticleId><ArticleId IdType="doi">10.1021/es5002105</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue J, Domingo-Almenara X, Guijas C et al (2020) Enhanced in-source fragmentation annotation enables novel data independent acquisition and autonomous METLIN molecular identification. Anal Chem 92:6051&#x2013;6059</Citation><ArticleIdList><ArticleId IdType="pubmed">32242660</ArticleId><ArticleId IdType="pmc">8966047</ArticleId><ArticleId IdType="doi">10.1021/acs.analchem.0c00409</ArticleId></ArticleIdList></Reference><Reference><Citation>Mamani-Huanca M, Gradillas A, Gil De La Fuente A et al (2020) Unveiling the fragmentation mechanisms of modified amino acids as the key for their targeted identification. Anal Chem 92:4848&#x2013;4857</Citation><ArticleIdList><ArticleId IdType="pubmed">32119527</ArticleId><ArticleId IdType="doi">10.1021/acs.analchem.9b04313</ArticleId></ArticleIdList></Reference><Reference><Citation>Mamani-Huanca M, Gradillas A, L&#xf3;pez-Gonz&#xe1;lvez &#xc1; et al (2022) In-source fragmentation for the identification of compounds by CE-ESI-TOF in human plasma. L-Proline as case study. Methods Mol Biol 2531:185&#x2013;202</Citation><ArticleIdList><ArticleId IdType="pubmed">35941486</ArticleId><ArticleId IdType="doi">10.1007/978-1-0716-2493-7_12</ArticleId></ArticleIdList></Reference><Reference><Citation>Mamani-Huanca M, Gradillas A, L&#xf3;pez-Gonz&#xe1;lvez &#xc1; et al (2020) Unraveling the Cyclization of l-Argininosuccinic acid in biological samples: a study via mass spectrometry and NMR spectroscopy. Anal Chem 92:12891&#x2013;12899</Citation><ArticleIdList><ArticleId IdType="pubmed">32822159</ArticleId><ArticleId IdType="doi">10.1021/acs.analchem.0c01420</ArticleId></ArticleIdList></Reference><Reference><Citation>Giera M, Yanes O, Siuzdak G (2022) Metabolite discovery: biochemistry&#x2019;s scientific driver. Cell Metab 34:21&#x2013;34</Citation><ArticleIdList><ArticleId IdType="pubmed">34986335</ArticleId><ArticleId IdType="pmc">10131248</ArticleId><ArticleId IdType="doi">10.1016/j.cmet.2021.11.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Palacios-Ce&#xf1;a D, G&#xf3;mez-Mayordomo V et al (2021) Defining post-COVID symptoms (Post-Acute COVID, Long COVID, Persistent Post-COVID): an integrative classification. Int J Environ Res Public Health 18:2621</Citation><ArticleIdList><ArticleId IdType="pubmed">33807869</ArticleId><ArticleId IdType="pmc">7967389</ArticleId><ArticleId IdType="doi">10.3390/ijerph18052621</ArticleId></ArticleIdList></Reference><Reference><Citation>Munipalli B, Seim L, Dawson NL et al (2022) Post-acute sequelae of COVID-19 (PASC): a meta-narrative review of pathophysiology, prevalence, and management. SN Compr Clin Med 4:1&#x2013;14</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-022-01167-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Guntur VP, Nemkov T, de Boer E et al (2022) Signatures of mitochondrial dysfunction and impaired fatty acid metabolism in plasma of patients with Post-Acute Sequelae of COVID-19 (PASC). Metabolites 12:1026</Citation><ArticleIdList><ArticleId IdType="pubmed">36355108</ArticleId><ArticleId IdType="pmc">9699059</ArticleId><ArticleId IdType="doi">10.3390/metabo12111026</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuligowski J, S&#xe1;nchez-Illana &#xc1;, Sanju&#xe1;n-Herr&#xe1;ez D et al (2015) Intra-batch effect correction in liquid chromatography-mass spectrometry using quality control samples and support vector regression (QC-SVRC). Analyst 140:7810&#x2013;7817</Citation><ArticleIdList><ArticleId IdType="pubmed">26462549</ArticleId><ArticleId IdType="doi">10.1039/C5AN01638J</ArticleId></ArticleIdList></Reference><Reference><Citation>Song JW, Lam SM, Fan X et al (2020) Omics-driven systems interrogation of metabolic dysregulation in COVID-19 pathogenesis. Cell Metab 32:188&#x2013;202.e5</Citation><ArticleIdList><ArticleId IdType="pubmed">32610096</ArticleId><ArticleId IdType="pmc">7311890</ArticleId><ArticleId IdType="doi">10.1016/j.cmet.2020.06.016</ArticleId></ArticleIdList></Reference><Reference><Citation>Barberis E, Timo S, Amede E et al (2020) Large-scale plasma analysis revealed new mechanisms and molecules associated with the host response to SARS-CoV-2. Int J Mol Sci 21:8623</Citation><ArticleIdList><ArticleId IdType="pubmed">33207699</ArticleId><ArticleId IdType="pmc">7696386</ArticleId><ArticleId IdType="doi">10.3390/ijms21228623</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Zheng X, Liu B et al (2021) Aspartate metabolism facilitates IL-1&#x3b2; production in inflammatory macrophages. Front Immunol 12:753092</Citation><ArticleIdList><ArticleId IdType="pubmed">34745126</ArticleId><ArticleId IdType="pmc">8567039</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2021.753092</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerard R, Hans B, Sibylle A et al (2019) CE/MS Principles and Practices A guidebook for novices and practitioners. &#xa9; Agilent Technologies, Inc</Citation></Reference><Reference><Citation>Dudzik D, Barbas-Bernardos C, Garc&#xed;a A et al (2018) Quality assurance procedures for mass spectrometry untargeted metabolomics. A review. J Pharm Biomed Anal 147:149&#x2013;173</Citation><ArticleIdList><ArticleId IdType="pubmed">28823764</ArticleId><ArticleId IdType="doi">10.1016/j.jpba.2017.07.044</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirwan JA, Gika H, Beger RD et al (2022) Quality assurance and quality control reporting in untargeted metabolic phenotyping: mQACC recommendations for analytical quality management. Metabolomics 18:70</Citation><ArticleIdList><ArticleId IdType="pubmed">36029375</ArticleId><ArticleId IdType="pmc">9420093</ArticleId><ArticleId IdType="doi">10.1007/s11306-022-01926-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Kauffmann HM, Kamp H, Fuchs R et al (2017) Framework for the quality assurance of &#x2018;omics technologies considering GLP requirements. Regul Toxicol Pharmacol 91:S27&#x2013;S35</Citation><ArticleIdList><ArticleId IdType="pubmed">28987912</ArticleId><ArticleId IdType="pmc">6816020</ArticleId><ArticleId IdType="doi">10.1016/j.yrtph.2017.10.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarmad S, Viant MR, Dunn WB et al (2023) A proposed framework to evaluate the quality and reliability of targeted metabolomics assays from the UK Consortium on Metabolic Phenotyping (MAP/UK). Nat Protoc 18:1017&#x2013;1027</Citation><ArticleIdList><ArticleId IdType="pubmed">36828894</ArticleId><ArticleId IdType="doi">10.1038/s41596-022-00801-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Armitage EG, Godzien J, Alonso-Herranz&#x2019;angeles V et al (2015) Missing value imputation strategies for metabolomics data. Electrophoresis 36:3050&#x2013;3060</Citation><ArticleIdList><ArticleId IdType="pubmed">26376450</ArticleId><ArticleId IdType="doi">10.1002/elps.201500352</ArticleId></ArticleIdList></Reference><Reference><Citation>Kessler N, Neuweger H, Bonte A et al (2013) Data and text mining MeltDB 20-advances of the metabolomics software system. Bioinformatics 29:2452&#x2013;2459</Citation><ArticleIdList><ArticleId IdType="pubmed">23918246</ArticleId><ArticleId IdType="pmc">3777109</ArticleId><ArticleId IdType="doi">10.1093/bioinformatics/btt414</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis TJ, Firzli TR, Keppler EAH et al (2022) Addressing missing data in GC &#xd7; GC metabolomics: identifying missingness type and evaluating the impact of imputation methods on experimental replication. Anal Chem 94:10912&#x2013;10920</Citation><ArticleIdList><ArticleId IdType="pubmed">35881554</ArticleId><ArticleId IdType="pmc">9369014</ArticleId><ArticleId IdType="doi">10.1021/acs.analchem.1c04093</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunn WB, Broadhurst D, Begley P et al (2011) Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc 6:1060&#x2013;1083</Citation><ArticleIdList><ArticleId IdType="pubmed">21720319</ArticleId><ArticleId IdType="doi">10.1038/nprot.2011.335</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirwan JA, Broadhurst DI, Davidson RL et al (2013) Characterising and correcting batch variation in an automated direct infusion mass spectrometry (DIMS) metabolomics workflow. Anal Bioanal Chem 405:5147&#x2013;5157</Citation><ArticleIdList><ArticleId IdType="pubmed">23455646</ArticleId><ArticleId IdType="doi">10.1007/s00216-013-6856-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleveland WS (1979) Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 74:829&#x2013;836</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01621459.1979.10481038</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleveland WS, Devlin SJ (1988) Locally weighted regression: an approach to regression analysis by local fitting. J Am Stat Assoc 83:596&#x2013;610</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01621459.1988.10478639</ArticleId></ArticleIdList></Reference><Reference><Citation>Bararpour N, Gilardi F, Carmeli C et al (2021) DBnorm as an R package for the comparison and selection of appropriate statistical methods for batch effect correction in metabolomic studies. Sci Rep 11:1&#x2013;13</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-84824-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen X, Gong X, Cai Y et al (2016) Normalization and integration of large-scale metabolomics data using support vector regression. Metabolomics 12:1&#x2013;12</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11306-016-1026-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X, Liang L (2022) metabolomicsR: a streamlined workflow to analyze metabolomic data in R. Bioinform Adv 2:vbac067</Citation><ArticleIdList><ArticleId IdType="pubmed">36177485</ArticleId><ArticleId IdType="pmc">9512519</ArticleId><ArticleId IdType="doi">10.1093/bioadv/vbac067</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H, Huan T (2022) MAFFIN: metabolomics sample normalization using maximal density fold change with high-quality metabolic features and corrected signal intensities. Bioinformatics 38:3429&#x2013;3437</Citation><ArticleIdList><ArticleId IdType="pubmed">35639662</ArticleId><ArticleId IdType="doi">10.1093/bioinformatics/btac355</ArticleId></ArticleIdList></Reference><Reference><Citation>Dieterle F, Ross A, Schlotterbeck G et al (2006) Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics. Anal Chem 78:4281&#x2013;4290</Citation><ArticleIdList><ArticleId IdType="pubmed">16808434</ArticleId><ArticleId IdType="doi">10.1021/ac051632c</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapp HS, Kemsley EK (2009) Notes on the practical utility of OPLS. TrAC Trends Analy Chem 28:1322&#x2013;1327</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trac.2009.08.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Drouin N, Van MM, Zhang W et al (2020) Capillary electrophoresis-mass spectrometry at trial by metabo-ring: effective electrophoretic mobility for reproducible and robust compound annotation. Anal Chem 92:14103&#x2013;14112</Citation><ArticleIdList><ArticleId IdType="pubmed">32961048</ArticleId><ArticleId IdType="pmc">7581015</ArticleId><ArticleId IdType="doi">10.1021/acs.analchem.0c03129</ArticleId></ArticleIdList></Reference><Reference><Citation>Neveu V, Nicolas G, Amara A et al (2023) The human microbial exposome: expanding the Exposome-Explorer database with gut microbial metabolites. Sci Rep 13:1&#x2013;12</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-26366-w</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>